Health and Healthcare Systems

One chart that shows equal access to vaccines isn’t just about health

A man receives a dose of a vaccine against the coronavirus disease (COVID-19) during a vaccination program in Jakarta, Indonesia, August 16, 2021.

The gulf in vaccine distribution between rich and poor nations is breathtaking and self-defeating. Image: REUTERS/Ajeng Dinar Ulfiana

Jatinder Sidhu
Writer, Forum Agenda
  • The World Bank expects the global economy to grow by 5.6% in 2021.
  • But it says the lingering pandemic could lead to a “faltering” global recovery.
  • A resurgence of COVID-19 cases and lagging vaccination progress are holding many countries back.

When will COVID-19 be over? It’s the question being asked by everyone from parents of young children to public health officials, economists to entrepreneurs the world over.

The global economy is expected to grow by 5.6% in 2021, the fastest post-recession pace in 80 years according to data from the World Bank’s Global Economic Prospects report. And while that recovery is expected to be uneven, the twice-yearly study suggests that developing economies will grow by 6% this year.

That figure is based on higher demand and elevated prices for commodities, many of which are produced by developing economies.

But the single greatest challenge remains COVID-19 itself.

Threat to recovery

Optimism over economic recovery is tempered by concerns about a resurgence of cases and the global inequities over access to vaccines.

An animated chart issued by the World Bank illustrates the problem clearly. The analysis revises the projected growth figure downwards (by 0.2 percentage points) for countries with below-median vaccination rates and upwards (by 0.8pp) for those with above-median vaccination rates.

Loading...

Vaccine inequity

The gulf in vaccine distribution between rich and poor nations is breathtaking and self-defeating.

The vaccination rate among rich countries is just over 51% according to the United Nations Development Programme (UNDP). It’s about 1.4% for low-income nations. The figure for the Democratic Republic of the Congo (population 89m) is less than 0.1% – or fewer than 1 in 1000 people.

Discover

What is the World Economic Forum doing about access to vaccines?

According to the Vaccine Equity Dashboard, a tool developed in conjunction with United Nations (UN) agencies and the University of Oxford, growth rates in poorer countries – where many health workers are still yet to be vaccinated – may not get back to pre-pandemic levels until 2024.

If low-income countries had the same vaccination rate as high-income countries, it says, they could add $38 billion to their GDP for 2021.

The dashboard also reports that on average the level of investment required to vaccinate 70% of the population is 0.8% of health budgets in rich countries compared to 56.6% in low-income countries.

High income countries: 1 in 2 people, or 51% have been vaccinated as of Aug 4, 2021.
High income countries: 1 in 2 people, or 51% had been vaccinated as of Aug 4, 2021. Image: UNDP

Global solutions

So what can be done to address the challenge? The focus has been on speeding up vaccine distribution to developing countries.

The global programme COVAX – conceived to give the whole world fair access to COVID-19 vaccines – has so far delivered more than 150 million vaccine doses around the world, with a target of making 2 billion available by the end of 2021. However, in June it warned that short-term supply concerns remain, particularly throughout July and August.

Alongside, the World Bank says developing countries could take action to boost growth. It urges measures to reduce trade costs – almost 50% higher in developing compared to advanced economies – and investments in green infrastructure and climate resilience.

The report warns of the possibility of a lingering pandemic contributing to a downside scenario of a “faltering” global recovery similar to that which followed the global financial crisis of 2007-8. As the oft-repeated mantra goes: no one is safe, unless everyone is safe.

Loading...
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

COVID-19

Share:
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

COPD kills more than lung and breast cancer combined. It's time to change that

Nitin Kapoor

November 22, 2024

A historic leap in cancer vaccines – here’s what you need to know

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum